摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[5-(pyrrolidin-1-ylmethyl)-1,3-thiazol-2-yl]ethynyl]pyrimidin-4-amine | 1198855-26-3

中文名称
——
中文别名
——
英文名称
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[5-(pyrrolidin-1-ylmethyl)-1,3-thiazol-2-yl]ethynyl]pyrimidin-4-amine
英文别名
——
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[5-(pyrrolidin-1-ylmethyl)-1,3-thiazol-2-yl]ethynyl]pyrimidin-4-amine化学式
CAS
1198855-26-3
化学式
C28H25ClFN5OS
mdl
——
分子量
534.057
InChiKey
KERGPNUFPFTXOL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    37
  • 可旋转键数:
    9
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    91.4
  • 氢给体数:
    1
  • 氢受体数:
    8

反应信息

  • 作为产物:
    参考文献:
    名称:
    Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinases
    摘要:
    5-Alkenyl or 5-alkynyl-4-anilinopyrimidines were prepared and evaluated for in vitro inhibition of EGFR/Her-2 kinase activity and the growth of tumor cell lines (BT474 and N87). Several of these compounds inhibited the growth of BT474 and N87 at concentrations below 200 nM. Structure-activity relationship studies revealed a critical role for the 5-alkynyl moieties. The representative compound 19 exhibited significant antitumor potency in a mouse xenograft model. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.10.103
点击查看最新优质反应信息

文献信息

  • Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinases
    作者:Naoyuki Suzuki、Takeshi Shiota、Fumihiko Watanabe、Norihiro Haga、Takami Murashi、Takafumi Ohara、Kenji Matsuo、Naoki Omori、Hiroshi Yari、Keiji Dohi、Makiko Inoue、Motofumi Iguchi、Jyunko Sentou、Tooru Wada
    DOI:10.1016/j.bmcl.2011.10.103
    日期:2012.1
    5-Alkenyl or 5-alkynyl-4-anilinopyrimidines were prepared and evaluated for in vitro inhibition of EGFR/Her-2 kinase activity and the growth of tumor cell lines (BT474 and N87). Several of these compounds inhibited the growth of BT474 and N87 at concentrations below 200 nM. Structure-activity relationship studies revealed a critical role for the 5-alkynyl moieties. The representative compound 19 exhibited significant antitumor potency in a mouse xenograft model. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多